Loading organizations...
Key people at RxAnte.
RxAnte is a health technology and services company providing advanced predictive analytics and clinical services to optimize medication use and improve health outcomes. It leverages patented technology, artificial intelligence, and machine learning to identify and mitigate risks of medication non-adherence and misuse, enhancing prescription drug effectiveness for complex patient populations.
Joshua S. Benner, PharmD, ScD, founded RxAnte in 2011. His foundational insight was that sophisticated data analytics and targeted interventions could dramatically improve medication adherence and patient outcomes. Benner envisioned a system to proactively address medication management, offering predictive insights into patient behavior and therapy effectiveness.
Serving health plans and value-based providers, RxAnte’s solutions empower these organizations to enhance care quality while reducing overall healthcare costs. The company’s vision is to help individuals on complex medication regimens live longer, healthier lives, ensuring they gain maximum benefit from prescribed medicines and realizing the full potential of pharmaceutical care.
Key people at RxAnte.
RxAnte is a healthcare technology company specializing in predictive analytics and clinical services to optimize medication use, improve health outcomes, and reduce costs for health plans, particularly Medicare Advantage plans.[2][3][5] It builds products like RxEffect, an adherence workflow solution for targeting and monitoring at-risk members, and Mosaic, a value-based pharmacy service offering in-person consultations, medication reviews, monthly refills in easy packaging, and 24/7 pharmacist support for medically complex Medicare patients managing multiple chronic conditions.[1][4][5] RxAnte serves health plans and value-based providers, solving problems like poor medication adherence (affecting 36% of seniors on 5+ medications daily), suboptimal pharmacy quality measures (driving 68% of Star Ratings), and high total cost of care through patented analytics, simulations, and tech-enabled interventions.[4][5] The company manages over 30 million health plan lives, delivers proven quality gains and cost reductions, and boasts an 85 NPS for Mosaic.[4][5]
RxAnte emerged as a UPMC Enterprises portfolio company, focusing on predictive analytics to address medication adherence challenges in healthcare.[1][7] While exact founding details are not specified in available sources, its development ties to collaborations with health plans; a pivotal early moment was the 2017 launch of RxEffect with a regional health plan, targeting 7,398 unique patients for diabetes, RASA, and statin adherence, achieving 92% prediction accuracy on year-end adherence for ~47,000 MAPD patients.[6] By 2019, RxAnte expanded into direct-to-member services with Mosaic, building on work identifying at-risk patients to intervene on therapy problems, marking a shift toward comprehensive, value-based pharmacy care.[1] This evolution reflects founders' and team's expertise in pharmacy analytics, humanizing RxAnte as a partner turning data into actionable patient care.[4][5]
RxAnte rides the wave of value-based care and Medicare Advantage growth, where medication non-adherence drives 68% of Star Ratings and elevates costs for 36% of polypharmacy seniors.[4] Timing aligns with rising demand for pharmacy care management (PCM) amid chronic disease prevalence and regulatory pressures on quality scores, enabling health plans to lower total care costs while enhancing member experience.[2][3][5] Market forces like risk-bearing arrangements for providers and data-driven interventions favor RxAnte's analytics, which forecast trajectories and activate networks at scale.[4][5] It influences the ecosystem by partnering with plans (30M+ lives) and providers, setting standards for predictive pharmacy tech and paving the way for AI-enhanced adherence in a $600B+ U.S. pharmacy market.[4][6]
RxAnte is poised to expand Mosaic and RxEffect amid Medicare Advantage enrollment surges and payer focus on Star Ratings, potentially scaling to more value-based providers via integrations with EHRs and telehealth.[4][5] Trends like AI-driven personalization and hybrid pharmacy models will shape its path, amplifying guarantees on quality/cost metrics. Its influence may evolve from analytics leader to full-stack pharmacy orchestrator, delivering "the right solution for the right patient at the right time" and redefining adherence in tech-enabled care.[4] This positions RxAnte as a cornerstone for health plans getting more from medicines.
